Harmony Biosciences Holdings, Inc. HRMY
Set alert
38.80 USD +0.89 +2.35%
As of Nov 3, 9:52 AM ET
37.75 Day range 38.74
26.54 52-week range 42.86
- YTD
- +3.69%
- 1 year
- +32.29%
- Open
- 37.97
- Prev close
- 37.91
- Mkt cap
- 2.23B
- Vol
- 28.22K
- Avg vol
- 959.36K
- EPS
- 3.10
- P/E
- 12.37
- Div yield
- 0.00%
More statistics
- Low
- 37.75
- High
- 38.74
- Forward P/E
- 5.41
- Beta
- 0.98
- Short ratio
- 5.33
- Inst. own
- 100.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 39.76
- 200-d avg
- 34.69
- 1y target
- 48.08
Analyst view
Consensus: buy
Buy
Price target (mean) 48.08 +23.9% upside
Now 38.80
- Target (low)
- 30.00
- Target (mean)
- 48.08
- Target (high)
- 70.00
Ratings (0m) 12 8 buy · 3 hold · 1 sell
- Strong buy2
- Buy6
- Hold3
- Sell0
- Strong sell1
Recommendation trend
- This month 12
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.47 | 1.41 – 1.53 | 1.08 | +35.9% | 272.05M | +13.6% | 2 |
| Next quarter | 1.53 | 1.45 – 1.60 | 0.57 | +168.0% | 280.05M | +14.9% | 2 |
| Current year | 5.22 | 5.13 – 5.31 | 3.60 | +45.0% | 1.03B | +18.2% | 2 |
| Next year | 7.00 | 6.98 – 7.03 | 5.22 | +34.1% | 1.17B | +13.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Needham | Reiterated | Buy | Buy |
| Oct 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 12, 2026 | Needham | Reiterated | Buy | Buy |
| Aug 26, 2026 | Wolfe Research | Initiated | — | Outperform |
| Aug 5, 2026 | Truist Securities | Maintained | Hold | Hold |
| Aug 4, 2026 | Needham | Maintained | Buy | Buy |
| Jul 31, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 16, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 30, 2026 | Deutsche Bank | Maintained | Hold | Hold |
| May 8, 2026 | Truist Securities | Maintained | Hold | Hold |
| Feb 25, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 25, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 25, 2026 | B of A Securities | Maintained | Underperform | Underperform |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |
| Feb 11, 2026 | UBS | Downgrade | Buy | Neutral |
| Jan 8, 2026 | Truist Securities | Maintained | Buy | Buy |
| Dec 1, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 24, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 24, 2025 | Needham | Reiterated | Buy | Buy |
| Nov 6, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Oct 15, 2025 | UBS | Maintained | Buy | Buy |
| Sep 25, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Sep 25, 2025 | Deutsche Bank | Maintained | Buy | Buy |
| Sep 25, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 24, 2025 | Needham | Maintained | Buy | Buy |
| Jul 21, 2025 | Truist Securities | Initiated | — | Buy |
| Jul 10, 2025 | Deutsche Bank | Maintained | Buy | Buy |
| May 15, 2025 | Mizuho | Maintained | Outperform | Outperform |
| May 7, 2025 | Needham | Reiterated | Buy | Buy |
| May 6, 2025 | Needham | Reiterated | Buy | Buy |